This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.83% per year. These returns cover a period from January 1, 1988 through January 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
by Zacks Equity Research
Sector ETF report for FXH
Pharma & Healthcare ETFs at a One-Year High: Here's Why
by Sanghamitra Saha
Upbeat earnings, COVID-19-related sales, compelling valuation and lucrative dividend prospects are boosting pharma and healthcare ETFs.
Time for Pharma and Healthcare ETFs?
by Sanghamitra Saha
The broader medical sector should gain on decent earnings expectations and higher COVID-19-related sales
2 Sector ETFs Hovering Around All-Time Highs
by Sanghamitra Saha
The U.S. economic backdrop and investors' sentiments have remained mixed in recent weeks.
Are Healthcare ETFs Poised for a Comeback?
by Sanghamitra Saha
Decent earnings growth picture and valuation as well as solid deals activities have been favoring healthcare sector at the current level.
Healthcare ETF (FXH) Hits New 52-Week High
by Sanghamitra Saha
The fund FXH has hit a 52-week high on May 28. Can it rally further?
4 Sector ETF Winners of Bull Market Look Resilient to Virus
by Sanghamitra Saha
These sector ETFs emerged winners in the 11-year old bull market and may survive despite the coronavirus scare.
Solid US Labor Market Puts Focus on 3 Sector ETFs & Stocks
by Sanghamitra Saha
The U.S. labor market has been in great shape defying slowdown worries. Unemployment rate fell to a fresh 49-year low in April. Play this optimism with these sector ETFs and stocks.
3 Sector ETFs & Stocks to Shine on Upbeat March Jobs Data
by Sanghamitra Saha
March jobs report beat expectations in the United States. These sectors have added maximum jobs and thus put the following ETFs in focus.
4 Sector ETFs That Crushed S&P 500 in Decade-Old Bull Run
by Sanghamitra Saha
These sector ETFs emerged winners in the 10-year old bull market.